COVID mRNA vaccines may be able to train immune system to attack cancer cells, boost survival
At the time of data collection, some patients were still alive, indicating that the vaccine effects could be even stronger.Survival...
Year: 2025
Study finds no link between mRNA COVID vaccines early in pregnancy and birth defects
mRNA COVID-19 vaccination in the first trimester of pregnancy isn't tied to an elevated risk of 75 major congenital malformations...
Report proposes new framework to prepare for future pandemics
Nearly 5 years after the COVID-19 pandemic exposed significant gaps in pandemic preparedness, a new report is calling for a...
Data suggest 29% to 64% efficacy of 2024-25 COVID vaccine against poor outcomes in US veterans
The estimated effectiveness of last year's COVID-19 vaccine among US veterans was 29% against related emergency department (ED) visits, 39%...
Severe COVID may carry higher risk of long-term conditions requiring hospitalization through 6 months
A large real-world study suggests that while adults with mild or moderate COVID-19 are at only modestly greater risk of...
Data: Pediatric hospital strain amid 2022-23 respiratory virus season not tied to decline in beds
A Yale University–led research team reports that high US pediatric hospital bed occupancy (bed strain) and large differences in between-hospital...
Nearly 1 in 3 adults with severe long COVID have rare heart-rhythm disorder, data suggest
An uncommon heart-rhythm disorder occurs in nearly 1 in 3 adults with severe long COVID, most of them middle-aged women,...
CDC announces changes to COVID, childhood vaccines, touting ‘informed consent’
Today the Centers for Disease Control and Prevention (CDC) said it is now applying individual-based decision-making to COVID-19 vaccination instead...
US COVID activity falling
Another child has died from measles in Canada, this time a premature infant from Alberta, which has been experiencing a...
Trial: Paxlovid retreatment after COVID rebound tied to faster drop in viral RNA but no clinical benefit
A phase 2 randomized controlled trial published in Clinical Infectious Diseases finds that retreatment with the antiviral combination nirmatrelvir/ritonavir (Paxlovid) after...